References
- Lim S H, Zhang Y, Wang Z, Esler W V, Beggs D, Pruitt B, Hancock P, Townsend M. Maintenance rituximab after autologous stem cell transplant for high-risk B-cell lymphoma induces prolonged and severe hypogammaglobulinemia. Bone Marrow Transpl 2005; 35: 207–208
- Lim S H, Zhang Y, Wang Z, Varadarajan R, Periman P, Esler W V. Rituximab administration following autologous stem cell transplant for multiple myeloma is associated with severe IgM deficiency. Blood 2004; 103: 1971–1972
- Ashihara E, Shimazaki C, Yamagata N, Hirata T, Okawa K, Oku N, et al. Reconstitution of lymphocyte subsets after peripheral blood stem cell transplantation: two-color flow cytometric analysis. Bone Marrow Transpl 1994; 13: 377–381
- Koehne G, Zeller W, Stockschlaeder M, Zander A R. Phenotype of lymphocyte subsets after autologous peripheral blood stem cell transplantation. Bone Marrow Transpl 1997; 19: 149–156
- Talmadge J E, Reed E, Ino K, Kessinger A, Kuszynski C, Heimann D, et al. Rapid immunologic reconstitution following blood stem cells as compared to bone marrow. Bone Marrow Transpl 1997; 19: 161–172